Asbestos Cancer Litigation in the UK: What Every Property Owner and Employer Needs to Know
Asbestos cancer litigation has fundamentally reshaped the UK legal landscape over the past century. From the first recorded death from asbestosis in the early 1920s through to today’s sophisticated mass tort actions, the journey from hazardous material to courtroom has been driven by hard-won medical knowledge, landmark rulings, and the relentless pursuit of justice for people whose lives were cut short by preventable exposure.
If you own, manage, or are responsible for a property built before 2000, understanding how this litigation has evolved is not just legally relevant — it is essential for protecting yourself and the people in your care.
A Brief History of Asbestos Cancer Litigation in the UK
The dangers of asbestos were not a sudden revelation. Workers in asbestos factories during the Industrial Revolution were exposed to dangerous fibre concentrations daily, often with no protective equipment and no understanding of the long-term consequences.
The first recorded death from asbestosis in the 1920s began to shift awareness, albeit slowly. The Asbestos Industry Regulations introduced in 1931 were the first formal attempt to control occupational exposure, requiring companies to provide protective gear, limit asbestos handling, and improve ventilation.
These regulations were imperfect, but they established a critical principle: employers have a duty of care to protect workers from asbestos-related harm. That principle has underpinned every significant development in asbestos cancer litigation ever since.
In 1985, the UK banned the import of blue (crocidolite) and brown (amosite) asbestos — the two most hazardous forms. This was a watershed moment. It signalled that the state was prepared to intervene decisively, and it made it considerably easier for claimants to argue that employers had been negligent in continuing to use these materials.
By 1999, all forms of asbestos, including white chrysotile, were banned entirely. Any building constructed or refurbished before that date may contain asbestos-containing materials (ACMs), and any duty holder responsible for such a building carries legal obligations that cannot be ignored.
Landmark Cases That Shaped Asbestos Cancer Litigation
Several key legal rulings have defined the contours of asbestos cancer litigation in the UK. Each one has had practical consequences for how claims are brought, how liability is apportioned, and what victims can expect to receive.
The Fairchild Case
The Fairchild case is arguably the most significant ruling in UK asbestos litigation history. The House of Lords ruled that a claimant exposed to asbestos by multiple negligent employers could recover full damages from any one of them, even where it could not be proven which employer’s asbestos had caused the mesothelioma.
This was a major departure from traditional causation rules, which required claimants to prove on the balance of probabilities that a specific employer’s breach had caused their specific injury. For mesothelioma — a cancer theoretically triggered by a single fibre — that standard was practically impossible to meet. The Fairchild exception changed everything.
Barker v Corus and the Compensation Act
The Barker v Corus ruling initially threatened to undermine Fairchild by ruling that liability should be proportionate to the period of exposure each employer was responsible for. This would have dramatically reduced the compensation available to many victims.
Parliament responded swiftly. The Compensation Act reversed the proportionate liability approach for mesothelioma cases, restoring full joint and several liability for employers. Any negligent employer could once again be held responsible for the full amount of damages, regardless of their relative contribution to the exposure.
The House of Lords Ruling on Pleural Plaques
Not every ruling has favoured claimants. The House of Lords ruled that pleural plaques — scarring of the lung lining caused by asbestos exposure — do not in themselves constitute a compensable injury. This decision significantly limited the scope of claims, restricting compensation to more serious conditions such as mesothelioma, asbestosis, and asbestos-related lung cancer.
How Medical Advances Have Strengthened Asbestos Cancer Litigation
The evolution of asbestos cancer litigation has been inseparable from advances in medical science. In the early decades of litigation, proving a causal link between asbestos exposure and a specific disease was enormously difficult. Today, the evidentiary picture is far clearer.
Improved Diagnostic Tools
CT scans, biopsies, and high-resolution imaging have transformed the ability to identify asbestos-related diseases with precision. Mesothelioma — a cancer of the pleural lining or peritoneum — can now be diagnosed and staged with a level of accuracy that was simply not possible in earlier decades.
This matters enormously in litigation. Courts require clear proof that a claimant’s disease was caused by asbestos exposure, not by some other factor. Detailed pathology reports, imaging results, and expert medical testimony now provide that proof in a way that is difficult to challenge.
Epidemiological Evidence
Courts increasingly rely on epidemiological studies — large-scale population research that identifies patterns of disease linked to asbestos exposure. These studies have established beyond reasonable doubt that mesothelioma, asbestosis, and certain forms of lung cancer are caused by asbestos exposure.
That scientific consensus underpins virtually every successful claim brought today. Defendants face a much harder task in disputing causation when the medical evidence is clear, well-documented, and backed by decades of peer-reviewed research.
Secondary Exposure Claims
Medical understanding has also expanded the scope of who can bring a claim. Secondary exposure — where family members of asbestos workers were exposed to fibres brought home on clothing — is now recognised as a genuine and serious risk.
Cases involving secondary exposure are more complex to prove, but they are increasingly successful as medical evidence of the dose-response relationship between asbestos and disease becomes more refined. This is a significant development for asbestos cancer litigation, opening the door for victims who never set foot in an industrial workplace.
The Shift from Individual Claims to Mass Tort Litigation
As the scale of asbestos-related disease became apparent in the 1980s and 1990s, the legal system had to adapt. Individual claims gave way to mass tort actions, where law firms managed hundreds or thousands of cases simultaneously against common defendants.
This shift created significant pressure on the insurance industry and on the courts. Legal teams began initiating proceedings earlier to counter deliberate delays by insurers, who frequently demanded extensive documentation before acknowledging liability.
The Mesothelioma Fast Track process was introduced to address this, requiring interim payments within 21 days in cases where no credible defence had been raised. The practical lesson for property owners and employers is straightforward: asbestos cancer litigation is no longer a niche area of law. It is a well-resourced, highly organised field where claimants have access to specialist legal teams and established procedural mechanisms designed to secure compensation efficiently.
Trust Funds and Compensation Schemes
One of the most significant developments in asbestos cancer litigation has been the creation of dedicated compensation schemes and trust funds. These mechanisms allow victims to receive payments without the time, cost, and uncertainty of full court proceedings.
The Diffuse Mesothelioma Payment Scheme is the most prominent example. It provides financial support to mesothelioma patients who cannot trace a former employer or their insurer. The scheme is funded by active insurers in the UK market and has provided a vital safety net for patients who would otherwise face lengthy and often fruitless legal searches.
Trust funds have also become a feature of asbestos litigation in cases involving companies that have become insolvent. Many of the largest asbestos users in the UK — shipyards, construction firms, insulation manufacturers — no longer exist. Trust funds established from their assets allow claims to be processed and paid without the need for active litigation against a dissolved entity.
For claimants, the key advantage of these schemes is speed. Mesothelioma is an aggressive cancer with a poor prognosis. Many victims do not survive long enough to see a traditional court case concluded. Compensation schemes and trust funds provide a faster route to financial security for victims and their families.
The Role of Scientific Evidence in Modern Asbestos Cancer Litigation
Courts today expect a high standard of scientific rigour in asbestos cancer litigation. Expert witnesses — typically consultant physicians, occupational health specialists, and pathologists — play a central role in establishing the link between a claimant’s exposure history and their diagnosis.
Epidemiological evidence is particularly powerful. Studies tracking large populations of workers in industries such as shipbuilding, construction, and insulation have demonstrated clear dose-response relationships between asbestos exposure and disease incidence. This body of research makes it very difficult for defendants to argue that asbestos was not the cause of a claimant’s mesothelioma or asbestosis.
However, the increased rigour cuts both ways. Claimants must be able to demonstrate specific exposure — where they worked, for how long, what materials they handled, and what protective measures (if any) were in place. Detailed employment records, witness statements, and site surveys all contribute to building a robust case.
Challenges That Persist in Asbestos Cancer Litigation
Despite decades of legal development, asbestos cancer litigation remains genuinely challenging. Several issues continue to complicate claims and delay justice for victims.
Proving Exposure
Many claimants were exposed to asbestos decades ago, in workplaces that no longer exist and by employers who have since dissolved. Employment records from the 1950s, 1960s, and 1970s are often incomplete or lost entirely.
Reconstructing a credible exposure history requires careful detective work — tracking down former colleagues, consulting trade union records, and commissioning expert assessments of the likely asbestos content of specific work environments. This is time-consuming and expensive, and it places a significant burden on claimants who are often seriously ill.
The Latency Problem
Asbestos-related diseases have exceptionally long latency periods. Mesothelioma typically develops between 20 and 50 years after initial exposure. This means that many victims are diagnosed at an advanced age, with limited life expectancy and fading memories of the workplaces and employers responsible for their exposure.
The latency problem also complicates the identification of responsible parties. Companies that were negligent in the 1960s or 1970s may have changed ownership multiple times, merged with other businesses, or ceased trading altogether. Tracing the chain of liability requires specialist legal expertise.
Tracing Insurers
Even where a responsible employer can be identified, tracing their historical insurer is a further obstacle. Employers’ liability insurance policies from decades ago are often difficult to locate. The Employers’ Liability Tracing Office (ELTO) database has improved this process, but gaps remain, particularly for policies issued before electronic records became standard.
What This Means for Property Owners and Duty Holders Today
The history of asbestos cancer litigation sends a clear message to anyone responsible for a building constructed before 2000: the legal and financial consequences of failing to manage asbestos properly are severe, and they are not theoretical.
Under the Control of Asbestos Regulations, duty holders — including commercial landlords, employers, and building managers — are legally required to identify, assess, and manage any ACMs in non-domestic premises. Failure to comply is a criminal offence, and it creates the conditions for civil liability if someone is subsequently harmed.
The HSE’s guidance document HSG264 sets out the standard required for asbestos surveys. A management survey is required for all occupied non-domestic buildings. A refurbishment and demolition survey is required before any intrusive work begins. These are not optional extras — they are legal requirements.
The practical steps every duty holder should take are straightforward:
- Commission a professional asbestos management survey if one has not been carried out recently
- Maintain an up-to-date asbestos register for your property
- Ensure any ACMs identified are properly managed, monitored, or removed by a licensed contractor
- Provide relevant information to anyone who may disturb ACMs — contractors, maintenance staff, and tenants
- Review your asbestos management plan regularly and update it when circumstances change
Cutting corners on asbestos management is not a cost saving — it is a liability that can follow you through the courts for decades. The litigation history outlined above makes that abundantly clear.
How Asbestos Surveys Reduce Your Legal Exposure
A professionally conducted asbestos survey is your first and most important line of defence against the risks described in this article. It gives you accurate, documented knowledge of what ACMs are present in your building, where they are located, and what condition they are in.
That knowledge allows you to make informed decisions about management and remediation. It also creates a paper trail that demonstrates your compliance with the Control of Asbestos Regulations — which matters enormously if a claim is ever brought against you.
Supernova Asbestos Surveys operates across the UK, with specialist teams covering major cities and regions. Whether you need an asbestos survey in London, are managing a portfolio of properties across the North West and need an asbestos survey in Manchester, or require an asbestos survey in Birmingham ahead of planned refurbishment works, our UKAS-accredited surveyors deliver thorough, HSG264-compliant reports you can rely on.
Every survey we conduct is carried out by qualified professionals who understand both the technical requirements and the legal context. We do not cut corners, and neither should you.
Frequently Asked Questions
What diseases are typically involved in asbestos cancer litigation?
The most common diseases at the centre of asbestos cancer litigation are mesothelioma (a cancer of the pleural lining or peritoneum), asbestos-related lung cancer, and asbestosis (a chronic scarring of the lung tissue). Pleural plaques — scarring of the lung lining — have been ruled by the House of Lords not to constitute a compensable injury in themselves, though they can be relevant as evidence of exposure.
How long do I have to bring an asbestos disease claim?
In most cases, the limitation period for personal injury claims is three years from the date of diagnosis or from the date on which the claimant first had knowledge that their condition was linked to asbestos exposure. Because asbestos diseases have very long latency periods, the clock typically starts running from diagnosis rather than from the date of exposure. Specialist legal advice should be sought as early as possible, particularly given the aggressive progression of conditions such as mesothelioma.
Can a claim be brought if the employer no longer exists?
Yes. Several mechanisms exist to help claimants recover compensation even where the responsible employer has dissolved or become insolvent. The Diffuse Mesothelioma Payment Scheme provides payments to patients who cannot trace a former employer or insurer. Trust funds established from the assets of former companies also allow claims to be processed. The Employers’ Liability Tracing Office (ELTO) database can help locate historical insurance policies, though gaps in older records remain a challenge.
What is secondary asbestos exposure and can it form the basis of a claim?
Secondary asbestos exposure refers to exposure suffered by individuals who were not directly employed in asbestos-related work but came into contact with asbestos fibres indirectly — most commonly family members of workers who brought fibres home on their clothing. This type of exposure is now medically recognised as capable of causing mesothelioma and other asbestos-related diseases. Claims based on secondary exposure are more complex to prove but have been successfully brought in UK courts.
As a property owner, could I face asbestos cancer litigation?
Yes, potentially. If you are a duty holder under the Control of Asbestos Regulations and you fail to properly identify and manage ACMs in your building, and someone is subsequently harmed as a result of that failure, you could face both criminal prosecution and civil liability. The key to protecting yourself is demonstrating that you took all reasonable steps to comply with your legal obligations — and a professionally conducted, documented asbestos survey is central to that defence.
Speak to Supernova Asbestos Surveys Today
With over 50,000 surveys completed nationwide, Supernova Asbestos Surveys is the UK’s most trusted name in asbestos surveying. Our UKAS-accredited teams provide management surveys, refurbishment and demolition surveys, and asbestos testing services that meet the full requirements of HSG264 and the Control of Asbestos Regulations.
Do not wait for a legal problem to force your hand. Call us today on 020 4586 0680 or visit asbestos-surveys.org.uk to book a survey or request a quote. Protecting your property, your people, and your legal position starts with knowing what you are dealing with.